Theriva BiologicsTOVX
13F holders, Q3 2024 (September 30)18holders
$1.38avg. 13F price*
At the end of Q3 2024, 18 institutions reported holding Theriva Biologics Inc. (TOVX) in their 13F filings. The largest holders were Heights Capital Management, Inc. ($196K), Anson Funds Management LP ($192K) and Armistice Capital, LLC ($138K).
- Company
- Theriva Biologics Inc.
- CUSIP
- 87164U508
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 17 | $472K |
| Exits | 0 | $0 |
Ownership 18 holders
| Heights Capital Management, Inc. | 0.16% | — | 141,958 | $196K |
| Anson Funds Management LP | 0.03% | New | 139,046 | $192K |
| Armistice Capital, LLC | 0.00% | New | 100,000 | $138K |
| MSD Partners, L.P. | 0.02% | New | 27,316 | $38K |
| Morgan Stanley | 0.00% | New | 20,200 | $28K |
| UBS Group AG | 0.00% | New | 17,851 | $25K |
| Two Sigma Investments, LP | 0.00% | New | 13,566 | $19K |
| HRT Financial LP | 0.00% | New | 11,806 | $16K |
| Two Sigma Securities, LLC | 0.00% | New | 10,120 | $14K |
| BlackRock, Inc. | 0.00% | — | 7,568 | $10K |
| Osaic Holdings, Inc. | 0.00% | New | 1,294 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 661 | $912 |
| Barclays PLC | 0.00% | New | 495 | $683 |
| Iron Horse Wealth Management, LLC | 0.00% | New | 14 | $19 |
| IFP Advisors, Inc | 0.00% | New | 11 | $15 |
| Bank of America Corp. | 0.00% | New | 9 | $12 |
| Planning Capital Management Corp | 0.00% | New | 4 | $6 |
| Danske Bank A/S | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is TOVX's weight in each manager's 13F, not the share of Theriva Biologics Inc. the manager owns.